Natural Compound Blocks New Cancer Cell Energy Pathway Identified

A natural substance derived from ginger has been found to disrupt an emerging energy pathway in cancer cells, offering new possibilities for targeted therapies and cancer treatment strategies.
Researchers from Osaka Metropolitan University have uncovered a promising natural compound that can interfere with a novel energy pathway used by certain cancer cells. The compound, ethyl p-methoxycinnamate, a key component of kencur ginger, was shown to inhibit the production of ATP—the energy molecule vital for cell survival—by disrupting fatty acid synthesis and lipid metabolism. Interestingly, instead of targeting glycolysis, which is the common energy source in cancer cells, this compound affects alternative metabolic routes. When exposed to ethyl p-methoxycinnamate, cancer cells increased glycolytic activity as a survival response, indicating an adaptive mechanism that prevents cell death. These insights expand our understanding of cancer metabolism, particularly the Warburg effect, and open new avenues for therapeutic strategies. The study suggests that targeting fatty acid synthesis pathways could be an effective approach in cancer treatment, especially given the compound's ability to cripple ATP production without inducing apoptosis. The findings highlight the importance of exploring natural substances for novel anti-cancer agents and contribute to the growing field of cancer metabolism research.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
How Routine Blood Tests Can Predict Outcomes in Spinal Cord Injury Patients
New research shows that routine blood samples analyzed with machine learning can predict spinal cord injury severity and outcomes early after injury, improving prognosis and treatment decisions.
Innovative Wearable Sensor Detects Sweat Biomarkers at Low Perspiration Levels
A revolutionary wearable device from Penn State can detect sweat biomarkers at extremely low perspiration levels, enabling non-invasive health monitoring even in resting or low-activity states.
Can Reducing Inflammation Alleviate Fatigue in Early-Stage Breast Cancer Patients?
New research reveals that inflammation may significantly contribute to fatigue in women with early-stage breast cancer, opening avenues for targeted treatments to improve patient quality of life.



